Risk Management of HPV+ Women: The case for integrating p16/Ki-67 dual stain .
From Denise Croix on May 5th, 2021
Dr. Tom Wright is an internationally recognized expert who has been instrumental in key clinical trials driving the development of novel diagnostics in the field of cervical cancer. In his 48 minute presentation, Dr. Wright:
- Provides evidence for primary HPV screening,
- Reviews multiple key trials showing the clinical utility of p16/Ki-67 dual stain for the triage of HPV+ women in both primary HPV testing and co testing screening methods
- Discusses how this assay fits in the current ASCCP guidelines for management of HPV + women
This presentation was previously presented at ASCCP April 8, 2021.